| Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST) (NCT02797626) | Heinrich-Heine University, Duesseldorf | 2016-06-01 |
| Efficacy and Safety of Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates (NCT02774044) | Ramesh K Agarwal | 2016-06-01 |
| Tipifarnib in Subjects With Myelodysplastic Syndromes (NCT02779777) | Kura Oncology, Inc. | 2016-06-01 |
| Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN Loss (NCT02822482) | UNICANCER | 2016-06-01 |
| Chidamide Plus DCAG for Relapsed/Refractory AML (NCT02886559) | Chinese PLA General Hospital | 2016-06-01 |
| Serial mpMRI (Multi Parametric Magnetic Resonance Imaging) Scanning in Prostate Cancer After Androgen Deprivation Therapy and RadioTherapy (NCT02721784) | University College, London | 2016-06-01 |
| Study of Benralizumab (KHK4563) in Patients With Eosinophilic Chronic Rhinosinusitis (NCT02772419) | Kyowa Kirin Co., Ltd. | 2016-06-01 |
| Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia (NCT02700048) | University of Minnesota | 2016-06-01 |
| A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test (NCT02790437) | Hansa Biopharma AB | 2016-06-01 |
| Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma (NCT02844439) | Kadmon Corporation, LLC | 2016-06-01 |
| Imaging Inflammation in Alzheimer's Disease (NCT02831283) | Patrick Lao | 2016-06-01 |
| UCMSC Transplantation in the Treatment of Cartilage Damage (NCT02776943) | South China Research Center for Stem Cell and Regenerative Medicine | 2016-06-01 |
| Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon (NCT02688270) | Covis Pharma S.à.r.l. | 2016-06-01 |
| Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects (NCT02886793) | Joan Albert Barbera Mir | 2016-06-01 |
| Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure (NCT02775539) | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | 2016-06-01 |
| Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population. (NCT02567149) | University of Minnesota | 2016-06-01 |
| Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine (NCT02745392) | Zosano Pharma Corporation | 2016-06-01 |
| Intravitreal Conbercept for Idiopathic Choroidal Neovascularization (NCT02857517) | Jiao Mingfei | 2016-06-01 |
| BRAF/MEK Inhibition in Relapsed/Refractory Multiple Myeloma (BIRMA) (NCT02834364) | University of Heidelberg Medical Center | 2016-06-01 |
| Analgesia in Knee Arthroscopic Surgery (NCT02818985) | Assiut University | 2016-06-01 |
| Abituzumab in SSc-ILD (NCT02745145) | EMD Serono Research & Development Institute, Inc. | 2016-05-31 |
| Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y) (NCT04439123) | National Cancer Institute (NCI) | 2016-05-31 |
| A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer (NCT02755272) | Fox Chase Cancer Center | 2016-05-31 |
| Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B) (NCT04439201) | National Cancer Institute (NCI) | 2016-05-31 |
| Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer (NCT02777385) | Dan Zandberg | 2016-05-31 |
| Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma (NCT02456714) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2016-05-31 |
| Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W) (NCT04439240) | National Cancer Institute (NCI) | 2016-05-31 |
| Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D) (NCT04439214) | National Cancer Institute (NCI) | 2016-05-31 |
| Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224) (NCT02702414) | Merck Sharp & Dohme LLC | 2016-05-31 |
| Genetic Predictors of Benefit to Pembrolizumab (NCT02710396) | Columbia University | 2016-05-31 |
| Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A) (NCT04439344) | National Cancer Institute (NCI) | 2016-05-31 |
| Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome (NCT02930161) | POLYSAN Scientific & Technological Pharmaceutical Company | 2016-05-30 |
| Evaluation of the Efficacy of Diuretics for Symptomatic Malignant Ascites Episodes in Advanced Stage of Cancer (DIASC) (NCT02501213) | Centre Oscar Lambret | 2016-05-30 |
| A Phase II Pilot Study to Assess the Presence of Molecular Factors Predictive for Hematologic Response in Myelodysplastic Syndrome Patients Receiving Deferasirox Therapy. (NCT02663752) | Novartis Pharmaceuticals | 2016-05-30 |
| IBP-9414 for the Prevention of Necrotizing Enterocolitis (NCT02472769) | Infant Bacterial Therapeutics | 2016-05-27 |
| Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (NCT02561000) | Tufts Medical Center | 2016-05-27 |
| Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD) (NCT02701634) | Gilead Sciences | 2016-05-27 |
| Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum (NCT02641691) | Washington University School of Medicine | 2016-05-27 |
| Viral Inhibition in Children for Treatment of RSV (NCT02654171) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2016-05-27 |
| Phase IIa Study of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (NCT02738775) | TG Therapeutics, Inc. | 2016-05-27 |
| Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic Analysis (NCT02628951) | Samsung Medical Center | 2016-05-26 |
| [68 Ga]-DOTANOC PET/CT in GEP-NETs (NCT02608203) | Assistance Publique Hopitaux De Marseille | 2016-05-26 |
| A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis (NCT02688647) | Kadmon Corporation, LLC | 2016-05-26 |
| A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia (NCT02780115) | Allergan | 2016-05-26 |
| Optimizing the Interval Between Cycles of PRRT with 177lu-dotatate in Sstr2 Positive Tumors (NCT03454763) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2016-05-26 |
| Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy (NCT02710253) | M.D. Anderson Cancer Center | 2016-05-25 |
| Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma (NCT02793583) | TG Therapeutics, Inc. | 2016-05-25 |
| Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) (NCT02764541) | Dana-Farber Cancer Institute | 2016-05-24 |
| Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites (NCT02436876) | Microbion Corporation | 2016-05-24 |
| A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients (NCT02649218) | Novartis Pharmaceuticals | 2016-05-24 |
| A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer (NCT02675231) | Eli Lilly and Company | 2016-05-23 |
| Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors (NCT02762981) | Corcept Therapeutics | 2016-05-23 |
| Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer (NCT02345265) | National Cancer Institute (NCI) | 2016-05-23 |
| A Study to Detect V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) V600 Mutation on Cell-Free Deoxyribonucleic Acid (cfDNA) From Plasma in Participants With Advanced Melanoma (NCT02768207) | Hoffmann-La Roche | 2016-05-23 |
| R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (NCT02628405) | Academic and Community Cancer Research United | 2016-05-20 |
| A Pilot Study to Evaluate the Effectiveness of Ultrasound Guided Looped Thread Carpal Tunnel Release (NCT03476486) | University of Alberta | 2016-05-20 |
| FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging (NCT02773238) | University of Washington | 2016-05-20 |
| SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study (NCT02778867) | Children's Hospital Medical Center, Cincinnati | 2016-05-20 |
| Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors (NCT02639546) | Hoffmann-La Roche | 2016-05-20 |
| Adderall XR and Cognitive Impairment in MS (NCT02676739) | Sarah Morrow | 2016-05-20 |
| Personalized NK Cell Therapy in CBT (NCT02727803) | M.D. Anderson Cancer Center | 2016-05-19 |
| Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants (NCT02568566) | National Cancer Institute (NCI) | 2016-05-19 |
| Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer (NCT02750358) | Memorial Sloan Kettering Cancer Center | 2016-05-19 |
| A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer (NCT02711553) | Eli Lilly and Company | 2016-05-19 |
| Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma (NCT02339922) | University of Washington | 2016-05-19 |
| Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma (NCT02780310) | Memorial Sloan Kettering Cancer Center | 2016-05-19 |
| Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE) (NCT02655419) | Pfizer | 2016-05-19 |
| Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) (NCT02757105) | RedHill Biopharma Limited | 2016-05-19 |
| Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma (NCT02617849) | Wilson Miller | 2016-05-19 |
| Vascularised Sentinel Skin Flaps to Detect Rejection in Pancreas Transplantation (NCT03183258) | University of Oxford | 2016-05-19 |
| Nicotinamide Riboside in Systolic Heart Failure (NCT03423342) | University of Washington | 2016-05-19 |
| Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer (NCT02703623) | M.D. Anderson Cancer Center | 2016-05-18 |
| Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCC (NCT02707588) | Groupe Oncologie Radiotherapie Tete et Cou | 2016-05-18 |
| A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease (NCT02782663) | AbbVie | 2016-05-18 |
| Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of MCL (NCT02682641) | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 2016-05-18 |
| Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies (NCT02711137) | Incyte Corporation | 2016-05-18 |
| A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation (NCT02783690) | Mayo Clinic | 2016-05-18 |
| A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia (NCT02804178) | Millendo Therapeutics, Inc. | 2016-05-18 |
| Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome (NCT02595346) | University Hospital, Rouen | 2016-05-17 |
| Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer (NCT02732327) | Forest Laboratories | 2016-05-17 |
| Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease (NCT02462603) | Edison Pharmaceuticals Inc | 2016-05-17 |
| Miami Membrane for Potency (MMEP) Trial (NCT02710422) | University of Miami | 2016-05-17 |
| A Study of CLR325 in Chronic Stable Heart Failure Patients. (NCT02696967) | Novartis Pharmaceuticals | 2016-05-17 |
| Magnesium Supplementation in People With XMEN Syndrome (NCT02496676) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-05-17 |
| Effectiveness of Photobiomodulation and Manual Therapy Alone or Combined in TMD Patients (NCT03454581) | Federal University of Rio Grande do Sul | 2016-05-17 |
| Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin (NCT02609503) | UNC Lineberger Comprehensive Cancer Center | 2016-05-16 |
| Evaluating the Safety and Tolerability of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults (NCT02475655) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-05-16 |
| Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer (NCT02489214) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2016-05-16 |
| Evaluation of Clinical Efficacy of Autologous Adipose Tissue Derived ADSCSs in Treatment of Osteoarthritis (OA) (NCT05484856) | Dr. Himanshu Bansal Foundation | 2016-05-16 |
| A Study of LY2880070 in Participants With Advanced or Metastatic Cancer (NCT02632448) | Esperas Pharma Inc. | 2016-05-16 |
| Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis (NCT02770170) | Boehringer Ingelheim | 2016-05-16 |
| Complement Inhibitor Eculizumab in Clinical Islet Transplantation (NCT02727608) | Uppsala University | 2016-05-15 |
| Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma (NCT02730819) | Mayo Clinic | 2016-05-15 |
| Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma (NCT02758717) | Academic and Community Cancer Research United | 2016-05-13 |
| A Trial of Lidocaine Patch for Lower Limb Amputation Pain (NCT02696720) | Brugmann University Hospital | 2016-05-13 |
| Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism (NCT02730169) | Mereo BioPharma | 2016-05-12 |
| Carnosine for Peripheral Arterial Disease (NCT04870229) | University of Louisville | 2016-05-12 |
| AASUR in High Risk Prostate Cancer (NCT02772588) | Memorial Sloan Kettering Cancer Center | 2016-05-12 |
| Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD (NCT02406651) | EVIVE Biotechnology | 2016-05-12 |
| NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer (NCT03862144) | Consorzio Oncotech | 2016-05-12 |